MODIFICATION
A -- Defense Sciences Research and Technology
- Notice Date
- 3/11/2005
- Notice Type
- Modification
- NAICS
- 541710
— Research and Development in the Physical, Engineering, and Life Sciences
- Contracting Office
- Other Defense Agencies, Defense Advanced Research Projects Agency, Contracts Management Office, 3701 North Fairfax Drive, Arlington, VA, 22203-1714
- ZIP Code
- 22203-1714
- Solicitation Number
- BAA05-19
- Response Due
- 2/7/2006
- Archive Date
- 2/8/2006
- Point of Contact
- Brett Giroir, Deputy Director, DSO, Phone (571) 218-4224, Fax (571) 218-4553,
- E-Mail Address
-
bgiroir@darpa.mil
- Description
- WAVEFORMS FOR ACTIVE SENSING, SOL BAA05-19, Addendum 3, DUE: 4/25/05, 400pm ET, POC: Douglas Cochran, DARPA/DSO, Ph: (703) 696-2287. Email: baa05-19@darpa.mil, URL: www.darpa.mil/dso. Website Submission: http://www.sainc.com/dso0519/ DESCRIPTION The Defense Sciences Office is soliciting innovative proposals to develop waveform design and scheduling methodologies for active sensing systems. Recent technological advances have enabled marked increases in radio-frequency (RF), optical, and acoustic transmitter agility. The goal of this initiative is development of new waveform and waveform family designs, scheduling techniques, and design tools, based upon rigorous mathematical foundations, to exploit this agility in applications of interest to the Department of Defense (DoD). Of particular interest are approaches that simultaneously utilize agility at the transmitter and adaptivity of receiver processing to fully exercise the: temporal, spatial, and spectral degrees of freedom entailed in modern and emerging DoD sensing applications. This program is anticipated to be executed in two phases. Phase I is expected to run for 15 months and will emphasize mathematical development of new approaches with validation through simulation and possibly laboratory demonstrations. Phase II is planned to run for 21 months and will entail refinement of the techniques developed in Phase I in conjunction with validation and demonstration in DoD-relevant testbed applications. Proposals should address both program phases and should budget Phase II as an option. Full proposals only are being accepted with the technical proposals being no more than twenty (20) pages, including cover sheet information and references. No addenda (e.g., reprints of published papers or technical reports) beyond the 20-page limit will be considered in the evaluation process. Proposals must contain the following elements: (1) Explicit description of one or more DoD-relevant application scenarios around which the project will be focused; (2) Precise quantification of the performance improvements sought via exploitation of waveform agility in the context of the focus application or applications; (3) Concise enumeration of the research challenges entailed in attaining the desired performance improvements sought, the approaches to be used to address these challenges; and (4) Plans for measuring the performance of the new techniques in simulation, laboratory, and testbed environments. One or more specific, quantitative milestones against which performance of the techniques developed will be benchmarked before the end of Phase I must be explicitly stated in the proposal. Similar milestones for the end of Phase II are also of interest, but these may be modified prior to the selection point for exercise of Phase II options based on insights gained in Phase I research. Successful proposals will aim at achieving significant, quantifiable improvement over current sensing capabilities and will set forth integrated projects, including personnel and facilities, that comprehensively span basic mathematical development through testbed demonstration. Teaming of academic and industrial performers as well as partnership with DoD laboratories and other capable testbed demonstration facilities are encouraged to facilitate the proposal of integrated projects. Letters from DoD or other Government laboratories indicating interest in partnership in the proposed project, particularly in validation and demonstration aspects, may be appended to the proposal and will not count against the 20-page limit. Full proposals are due no later than 4:00 pm ET, April 25, 2005. Proposals submitted after this time may not be considered. Please put the phrase “Waveforms for Active Sensing” in the title of the proposal to ensure proper routing. For details on proposal format and other aspects of full proposal submission, please see original FEDBIZOPS solicitation, BAA05-19, the text of which is availables also desirable. A critical component of a successful effort is a series of technology demonstrations that will occur regularly throughout the two year work period. These demonstrations will show clear progress toward the goal of delivering a mature arm prosthesis system that meets the requirements for an FDA IND at the end of the two year research and development period. The series will culminate in a demonstration of the complete functional arm system at the conclusion of the project. The formation of multidisciplinary teams with an overall system integrator as the lead institution is essential for effective program planning and execution. Proposals must describe plans to address the technical, commercial, and regulatory issues pertinent to integration of state of the art technologies into a new medical device. The emphasis of this two year effort is on the technical aspects of the upper arm prosthesis system. Commercial development and regulatory approval plans will be used to evaluate the ability of the proposers to ultimately deliver a prosthetic limb that will be widely available to the amputee community. An optional third year of effort should be proposed for the purpose of performing an early clinical trial. Only exceptionally successful programs will be considered for support in the third year. Each proposal should explicitly address tests, demonstrations, and other research activities planned in the area(s) of interest described above; include at least five specific, quantitative 12 month technical objectives that clearly demonstrate the research is on track for meeting the ultimate program goals; and include clear intellectual property arrangements, commercialization plans and transition paths. Upon award, specific deliverables and appropriate demonstrations of the science and/or technology elements will be required periodically and a final demonstration of the deliverable system is required at the end of the program. Proposed efforts should not exceed 24 months plus an optional third year for early clinical trials. If multiple awards are made a down-selection may occur after 12 months based on technical progress and achievements. Proposals with cost share should clearly identify the specific tasks to be cost shared in the technical proposal and separately break out the corresponding costs in the cost proposal. The number of awards will be dependent on the suitability of proposals received and availability of funds. Only full proposals are being accepted under this addendum. Proposals shall conform to the guidelines in DARPA (DSO) BAA05-19 (Parts 1 & 2) of 8 Feb, 2005 (http://www.darpa.mil/dso/solicitations/solicit.htm). To receive consideration under this addendum PROPOSALS ARE DUE TO THE ADDRESS SHOWN BELOW NO LATER THAN 4:00 PM ET 1 JUNE 2005. Proposals received after that date will be considered under the open BAA but not this addendum. Evaluation of the proposals will be in accordance with BA05-19. Please refer to the original FedBizOpps announcement for BAA 05-19 (Parts 1 and 2) for general administrative questions. Proposals involving human use that are selected for funding will be required to comply with provisions of the Common Rule (32 CFR 219) on the protection of human subjects in research (http://www.dtic.mil/biosys/downloads/32cfr219.pdf) and the DoD Directive 3216.2 (http://www.dtic.mil/whs/directives/corres/html2/d32162x.htm). All proposals that involve the use of human subjects are required to include documentation of their ability to follow Federal guidelines for the protection of human subjects. This includes, but is not limited to, protocol approval mechanisms, approved Institutional Review Boards (IRB), and Federal Wide Assurances. These requirements are based on expected human use issues sometime during the entire length of the proposed effort. For proposals involving "greater than minimal risk" to human subjects within the first year of the project, performers must provide evidence of protocol submission to a Federally approved IRB at the time of final proposal submission to DARPA. For proposals that are forecasted to involve "greater than minimal risk" after the first year, a discussion on how and when the proposer will comply with submission to a Federally approved IRB needs to be provided in the submission. More information on applicable Federal regulations can be found at the Department of Health and Human Services Office of Human Research Protections website (http://www.dhhs.gov/ohrp/). ADDRESSES FOR SUBMISSION: Web address for Full Proposal Submission: http://www.sainc.com/dso0519/ DARPA/DSO ATTN: BAA05-19 Addendum 4 3701 North Fairfax Drive Arlington, VA 22203-1714 Electronic Mail: BAA05-19@darpa.mil In all correspondence, reference BAA05-19, Addendum 4. Technical Point of Contact: Dr. Geoffrey Ling, DARPA/DSO; Phone: (571) 218-4674; E-mail: gling@darpa.mil. NOTE: THIS NOTICE MAY HAVE POSTED ON WWW.FEDBIZOPPS.GOV ON THE DATE INDICATED IN THE NOTICE ITSELF (11-MAR-2005). IT ACTUALLY APPEARED OR REAPPEARED ON THE FEDBIZOPPS SYSTEM ON 10-MAY-2005, BUT REAPPEARED IN THE FTP FEED FOR THIS POSTING DATE. PLEASE CONTACT fbo.support@gsa.gov REGARDING THIS ISSUE.
- Web Link
-
Link to FedBizOpps document.
(http://www.eps.gov/spg/ODA/DARPA/CMO/BAA05-19/listing.html)
- Record
- SN00804141-F 20050512/050510212342 (fbodaily.com)
- Source
-
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |